.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Reliable genetic diagnosis for craniofacial malformations depends on robust clinical evidence. Recently, the ClinGen Craniofacial Malformations Gene Curation Expert Panel (Cranio GCEP) completed its first evaluation of craniosynostosis gene classification. This systematic work provides expert guidance for clinicians to determine the validity of gene-disease relationships. Consequently, doctors can now rely on standardized data to establish more accurate genetic testing panels for skull abnormalities.
The expert panel selected twelve high-priority genes, including FGFR1, FGFR2, FGFR3, and TWIST1. They based their selection on literature reviews and current data from the Genetic Testing Registry. Throughout the curation process, the team identified 23 specific gene-disease pairs. Interestingly, 17 of these classifications (74%) reached the \"Definitive\" status. This level of certainty ensures that these genes are highly reliable markers for clinical diagnosis. However, six other pairs fell into \"Moderate\" or \"Limited\" categories, suggesting a need for further evidence.
Furthermore, these evidence-based findings help refine the diagnostic journey for pediatric patients. Since craniofacial malformations often require complex surgical interventions, knowing the exact genetic cause is vital. Additionally, the Cranio GCEP facilitates better education and collaboration among specialists. Therefore, this framework encourages the publication of new clinical cases to strengthen the \"Limited\" classifications. Moreover, it allows Indian clinicians to align their local diagnostic practices with global standards for craniosynostosis care.
A definitive classification means the evidence supporting the link between a gene and a disease is overwhelming. Consequently, clinicians can use these genes in diagnostic panels with high confidence in the results.
The panel confirmed definitive relationships for several genes, most notably FGFR1, FGFR2, FGFR3, and TWIST1. These genes are well-established causes of syndromic craniosynostosis.
By standardizing which genes actually cause skull abnormalities, it prevents the use of misleading markers in local genetic panels. This improves diagnostic accuracy and helps families receive more precise genetic counseling.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Edoh E et al. Evidence-based classification of genes implicated in craniosynostosis disorders using the ClinGen curation framework. Genet Med. 2026 Apr 29. doi: undefined. PMID: 42059179.
McClinchey A. Genetics and the role it plays in craniofacial anomalies. AME Case Rep. 2023;7:22.
Wilkie AO, et al. Clinical genetics of craniosynostosis. Curr Opin Pediatr. 2017;29(6):622-628.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The ClinGen Cranio GCEP curated 23 gene-disease pairs for craniosynostosis, classifying 74% as definitive to enhance clinical testing and patient care....
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
